Table 3.
SF-36 questionnaire scores
| Survey | SF-36 item | No delirium | Delirium | p (*) | VD.A (**) |
|---|---|---|---|---|---|
| SF-36 performed two years after hospital discharge, median, [IQR] | Limitations of activities | 67.5 [35–85] | 40 [2, 15–66] | < 0.001 | 0.707 b |
| Physical health problems | 75 [25–100] | 25 [0–75] | 0.002 | 0.68 b | |
| Emotional health problems | 100 [7–100] | 33.3 [0–100] | 0.005 | 0.656 b | |
| Energy | 50 [30–70] | 35 [15–50] | 0.004 | 0.689 b | |
| Mental health | 56 [40–72] | 36 [28–60] | 0.001 | 0.705 b | |
| Social activities | 75 [5, 50–87] | 50 [25–75] | 0.004 | 0.68 b | |
| Pain | 77.5 [65–100] | 67.5 [5, 45–77] | 0.03 | 0.639 b | |
| General health | 45 [35–50] | 40 [25–45] | < 0.001 | 0.713 a | |
| One-year health transition | 50 [30–50] | 25 [25–50] | < 0.001 | 0.307 b |
IQR interquartile range, VD.A Vargha and Delaney’s
(*) = Wilcoxon signed-rank test for related samples
(**) = Regarding size effect with VD.A:
aLarge effect (≥ 0.71 or ≤ 0.29)
bModerate effect (0.64–0.71 < or > 0.29–0.34)
cSmall effect (between 0.56–0.64 or 0.34–0.44). Values close to 1 or 0 indicate a strong intensity of the mean difference